BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 29897149)

  • 21. Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Santangeli P; Zado ES; Supple GE; Haqqani HM; Garcia FC; Tschabrunn CM; Callans DJ; Lin D; Dixit S; Hutchinson MD; Riley MP; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1413-21. PubMed ID: 26546346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence, Predictors, and Success of Ventricular Tachycardia Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (from the Nordic ARVC Registry).
    Christiansen MK; Haugaa KH; Svensson A; Gilljam T; Madsen T; Hansen J; Holst AG; Bundgaard H; Edvardsen T; Svendsen JH; Platonov PG; Jensen HK
    Am J Cardiol; 2020 Mar; 125(5):803-811. PubMed ID: 31924321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional isolation in the right atrium with disruption of intra-atrial conduction after catheter ablation of atrial tachycardia.
    Markowitz SM; Choi DY; Daian F; Liu CF; Cheung JW; Thomas G; Ip JE; Lerman BB
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1773-1785. PubMed ID: 31225670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.
    Protonotarios A; Anastasakis A; Panagiotakos DB; Antoniades L; Syrris P; Vouliotis A; Stefanadis C; Tsatsopoulou A; McKenna WJ; Protonotarios N
    Europace; 2016 Apr; 18(4):610-6. PubMed ID: 25825460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The left atrial substrate plays a significant role in the development of complex atrial tachycardia in patients with precapillary pulmonary hypertension.
    Fingrova Z; Havranek S; Ambroz D; Jansa P; Linhart A
    BMC Cardiovasc Disord; 2019 Jun; 19(1):157. PubMed ID: 31253083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial arrhythmias following surgical AF ablation: electrophysiological findings, ablation strategies, and clinical outcome.
    Huo Y; Schoenbauer R; Richter S; Rolf S; Sommer P; Arya A; Rastan A; Doll N; Mohr FW; Hindricks G; Piorkowski C; Gaspar T
    J Cardiovasc Electrophysiol; 2014 Jul; 25(7):725-38. PubMed ID: 24602079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of atrial arrhythmia radiofrequency catheter ablation in patients with Ebstein's anomaly.
    Hassan A; Tan NY; Aung H; Connolly HM; Hodge DO; Vargas ER; Cannon BC; Packer DL; Asirvatham SJ; McLeod CJ
    Europace; 2018 Mar; 20(3):535-540. PubMed ID: 28340054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling.
    Pump A; Di Biase L; Price J; Mohanty P; Bai R; Santangeli P; Mohanty S; Trivedi C; Yan RX; Horton R; Sanchez JE; Zagrodzky J; Bailey S; Gallinghouse GJ; Burkhardt JD; Natale A
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1224-31. PubMed ID: 24020717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgery for supraventricular tachycardia and congenital heart defects: long-term efficacy of the combined approach in adult patients.
    Giamberti A; Pluchinotta FR; Chessa M; Varrica A; Vitale R; Frigiola A; Pappone C; Ranucci M
    Europace; 2017 Sep; 19(9):1542-1548. PubMed ID: 27738072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of atrial arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis.
    Rujirachun P; Wattanachayakul P; Charoenngam N; Winijkul A; Ungprasert P
    J Cardiovasc Med (Hagerstown); 2020 May; 21(5):368-376. PubMed ID: 32243340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeat Procedures After Hybrid Thoracoscopic Ablation in the Setting of Longstanding Persistent Atrial Fibrillation: Electrophysiological Findings and 2-Year Clinical Outcome.
    Velagic V; DE Asmundis C; Mugnai G; Irfan G; Hunuk B; Stroker E; Hacioglu E; Umbrain V; Beckers S; Czapla J; Wellens F; Nijs J; Brugada P; LA Meir M; Chierchia GB
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):41-50. PubMed ID: 26374195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical experience with a novel multielectrode basket catheter in right atrial tachycardias.
    Schmitt C; Zrenner B; Schneider M; Karch M; Ndrepepa G; Deisenhofer I; Weyerbrock S; Schreieck J; Schömig A
    Circulation; 1999 May; 99(18):2414-22. PubMed ID: 10318663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease.
    Banchs JE; Baquero GA; Nickolaus MJ; Wolbrette DL; Kelleman JJ; Samii S; Grando-Ting J; Penny-Peterson E; Davidson WR; Young SK; Naccarelli GV; Gonzalez MD
    Congenit Heart Dis; 2014; 9(3):221-7. PubMed ID: 23947935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
    Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
    Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute and long-term outcome of focal atrial tachycardia ablation in the real world: results of the german ablation registry.
    Busch S; Forkmann M; Kuck KH; Lewalter T; Ince H; Straube F; Wieneke H; Julian Chun KR; Eckardt L; Schmitt C; Hochadel M; Senges J; Brachmann J
    Clin Res Cardiol; 2018 May; 107(5):430-436. PubMed ID: 29344680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience.
    Scheel PJ; Giuliano K; Tichnell C; James C; Murray B; Tandri H; Carter D; Fehr T; Umapathi P; Vaishnav J; Lewsey SC; Hsu S; Calkins H; Sharma K; Choi CW; Gilotra NA; Kilic A
    ESC Heart Fail; 2022 Apr; 9(2):1008-1017. PubMed ID: 34953065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac sympathetic dysfunction in genotyped patients with arrhythmogenic right ventricular cardiomyopathy and risk of recurrent ventricular tachyarrhythmias.
    Paul M; Wichter T; Kies P; Gerss J; Wollmann C; Rahbar K; Eckardt L; Breithardt G; Schober O; Schulze-Bahr E; Schäfers M
    J Nucl Med; 2011 Oct; 52(10):1559-65. PubMed ID: 21908389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment.
    Cappelletto C; Stolfo D; De Luca A; Pinamonti B; Barbati G; Pivetta A; Gobbo M; Brun F; Merlo M; Sinagra G
    Europace; 2018 Jun; 20(FI1):f20-f29. PubMed ID: 28633348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of ventricular arrhythmias with genotype in arrhythmogenic right ventricular cardiomyopathy.
    Bao J; Wang J; Yao Y; Wang Y; Fan X; Sun K; He DS; Marcus FI; Zhang S; Hui R; Song L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):552-6. PubMed ID: 24125834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of right and left atrial dilation and linear ablation for perpetuation of sustained atrial fibrillation.
    Zarse M; Deharo JC; Mast F; Allessie MA
    J Cardiovasc Electrophysiol; 2002 Feb; 13(2):164-71. PubMed ID: 11900292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.